» Articles » PMID: 33408079

Functional Genomics of Autoimmune Diseases

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2021 Jan 7
PMID 33408079
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

For more than a decade, genome-wide association studies have been applied to autoimmune diseases and have expanded our understanding on the pathogeneses. Genetic risk factors associated with diseases and traits are essentially causative. However, elucidation of the biological mechanism of disease from genetic factors is challenging. In fact, it is difficult to identify the causal variant among multiple variants located on the same haplotype or linkage disequilibrium block and thus the responsible biological genes remain elusive. Recently, multiple studies have revealed that the majority of risk variants locate in the non-coding region of the genome and they are the most likely to regulate gene expression such as quantitative trait loci. Enhancer, promoter and long non-coding RNA appear to be the main target mechanisms of the risk variants. In this review, we discuss functional genetics to challenge these puzzles.

Citing Articles

Promoter Polymorphism (Allelic Variation) Affects Tacrolimus Treatment Efficacy by Modulating E2F6 Binding Affinity.

Zheng X, Qin S, Zhong M, Xu Q, Huai C, Qiu X Biomedicines. 2025; 12(12.

PMID: 39767802 PMC: 11727355. DOI: 10.3390/biomedicines12122896.


Variants in the autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.

Wiley M, Khatri B, Joachims M, Tessneer K, Stolarczyk A, Rasmussen A bioRxiv. 2024; .

PMID: 39071447 PMC: 11275775. DOI: 10.1101/2023.10.05.561076.


The autoimmune tautology revisited.

Anaya J, Beltran S J Transl Autoimmun. 2024; 7:100204.

PMID: 38544807 PMC: 10966307. DOI: 10.1016/j.jtauto.2023.100204.


An update on the roles of transcription factor Ets1 in autoimmune diseases.

Garrett-Sinha L WIREs Mech Dis. 2023; 15(6):e1627.

PMID: 37565573 PMC: 10842644. DOI: 10.1002/wsbm.1627.


Microbiota-assisted therapy for systemic inflammatory arthritis: advances and mechanistic insights.

Li B, Yang B, Liu X, Zhao J, Ross R, Stanton C Cell Mol Life Sci. 2022; 79(9):470.

PMID: 35932328 PMC: 11072763. DOI: 10.1007/s00018-022-04498-6.